Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1544)	2/6/2006 4:54:15 PM
From: zeta1961	Respond to of 3722

Harry put out his Neuroinvestment newsletter today..dunno' just a thought.. Elisabeth

To: Jibacoa who wrote (1544)	10/24/2007 12:44:29 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NRMX Has been forming a base at the $2.65 level.At the time of the spike on Oct 17 it wasn't able to reach the $5 level.<g> (It needs to trade above $5 in order to close the DG of Aug 27 bigcharts.marketwatch.com On Aug 27 was when it announced that the PIII for ALZHEMED,didn't meet a statistically significant difference in its primary endpoints, although a substantial difference was observed in hippocampal volume,which did approach statistical significance. NRMX said that it had around $80 in cash, enough to carry it at its burn rate for 18 months.It has continued the PIII for ALZHEMED in Europe. With the tax season coming soon,it may be better to wait for further details on the European PIII, since there could be some people taking tax losses.<g> bigcharts.marketwatch.com Bernard